GeriPal

DECEMBER 15, 2022

Summary Transcript Summary. We’ve talked at length on prior podcasts about the failures of aducnumab, Biogen, and the FDA’s decision to approve it. . But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No No it’s not just the French version of Aducanumab). . In an article in the NEJM (a published article this time, wonder of wonders!)

IT 105

IT Patient-Centered Healthcare Illness 105

GeriPal

NOVEMBER 2, 2023

Jerry: Probably for the reason a lot of people go into geriatrics, close relationship with grandparents, volunteered to work in a nursing home as a high school student, just felt really good about being around old people and not having a problem with it. I’ve seen this question come up a lot since finishing fellowship nearly two decades ago.

Board-Certified 91

Board-Certified IT Community Medical Student 91

GeriPal

DECEMBER 8, 2022

Unpacking characteristics of spirituality through the lens of persons of colour living with serious illness: The need for nurse-based education to increase understanding of the spiritual dimension in healthcare. Eric’s blog post on Dignity Therapy from 2011. Summary Transcript Summary. Narrative medicine? Wonderful work. SPONSOR: .

Patient-Centered 115

Patient-Centered Illness Healthcare IT 115

GeriPal

APRIL 14, 2022

Our experts include Katie Fitzgerald Jones (palliative nurse practitioner and doctoral student at Boston College), Zachary Sager (palliative care physician at the Boston VA and Dana-Farber Cancer Institute), and Janet Ho (physician at UCSF in addiction medicine and palliative care). But does this drug really live up to the hype? Katie: Yeah.

Illness 102

Illness Patient-Centered IT Patients 102